Safety and Preliminary Clinical Activity of Itolizumab in Dermatomyositis

Condition:   Dermatomyositis, Adult Type Intervention:   Drug: Itolizumab Sponsor:   Biotech Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials